Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 85.59M | 80.95M | 69.23M | 58.27M | 55.09M | 51.06M |
Gross Profit | 30.11M | 32.46M | 35.26M | 31.34M | 30.98M | 24.56M |
EBITDA | 21.77M | 21.38M | 16.76M | 17.65M | 19.54M | 16.75M |
Net Income | 9.53M | 9.07M | 6.29M | 7.42M | 8.82M | 7.71M |
Balance Sheet | ||||||
Total Assets | 88.03M | 76.33M | 70.37M | 69.70M | 76.60M | 65.30M |
Cash, Cash Equivalents and Short-Term Investments | 24.83M | 25.07M | 26.56M | 35.82M | 47.42M | 35.10M |
Total Debt | 3.95M | 7.60M | 7.49M | 5.90M | 5.42M | 5.42M |
Total Liabilities | 52.80M | 45.69M | 43.66M | 42.45M | 37.35M | 33.83M |
Stockholders Equity | 32.84M | 28.00M | 24.01M | 25.39M | 37.00M | 29.21M |
Cash Flow | ||||||
Free Cash Flow | 1.55M | 6.14M | 2.88M | 9.90M | 16.48M | 9.73M |
Operating Cash Flow | 22.38M | 19.48M | 7.03M | 16.65M | 21.01M | 14.11M |
Investing Cash Flow | -21.21M | -13.24M | -4.64M | -7.27M | -4.30M | -4.84M |
Financing Cash Flow | 2.05M | -7.82M | -11.63M | -22.05M | -3.32M | -7.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | €646.30M | 15.05 | 16.30% | 1.75% | 8.63% | -3.90% | |
71 Outperform | €174.35M | 19.71 | 28.45% | 0.63% | 9.22% | 24.35% | |
70 Outperform | €37.19B | 36.39 | 19.28% | 0.83% | 12.80% | 662.68% | |
67 Neutral | €301.35B | 52.54 | 12.91% | 0.78% | 10.51% | 203.70% | |
56 Neutral | $3.18B | 5.08 | -5.68% | 5.65% | 8.05% | -41.83% | |
54 Neutral | €9.37M | ― | -16.98% | ― | -18.72% | -121.04% |